- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Vimentin (VIM) is a type III intermediate filament protein that is strongly expressed in neural-associated and mesenchymal cell types, where it plays a central role in cytoskeletal organization and cellular morphology. Vimentin Antibody is specifically positioned for immunofluorescence imaging of neural cytoskeleton structure, with strong relevance in glioblastoma models such as U251 as well as widely used cancer cell lines including A549 and HeLa. This aligns with search intent such as Vimentin immunofluorescence antibody, VIM IF antibody for neural cells, and neural cytoskeleton marker antibody. Vimentin is also referred to as Vimentin antibody, VIM antibody, and intermediate filament marker antibody in the literature, reinforcing alignment between gene, protein, and imaging-focused terminology.
In immunofluorescence and confocal microscopy, Vimentin forms a prominent filamentous network that is particularly well defined in neural-derived tumor cells such as U251 glioblastoma cells. Vimentin Antibody enables high-resolution visualization of these cytoskeletal structures, which extend from the perinuclear region to the cell periphery and define the elongated morphology commonly observed in neural and invasive cancer cells. This neural cytoskeleton immunofluorescence marker antibody positioning is a key differentiator, allowing researchers to study structural organization and morphological adaptation in glioblastoma and related models.
Beyond neural-derived cells, Vimentin is also expressed in epithelial-derived cancer cell lines such as A549 and HeLa, where it contributes to cytoskeletal remodeling and cellular plasticity. In fluorescence imaging workflows, Vimentin Antibody supports direct comparison of filament organization across diverse cell types, enabling analysis of cytoskeletal differences between neural tumor cells and non-neural cancer models. This makes it particularly valuable for studies examining morphology, migration, and structural heterogeneity across cancer systems.
Functionally, Vimentin interacts with actin filaments and microtubules to regulate cell shape, intracellular organization, and mechanical signaling. Its dynamic reorganization through phosphorylation supports processes such as mitosis, migration, and cytoskeletal remodeling, especially in highly plastic or invasive cells. The neural cytoskeleton immunofluorescence marker antibody differentiator is central to this antibody, positioning it specifically for fluorescence-based imaging of glioblastoma and neural-associated cytoskeletal networks rather than EMT or tumor microenvironment-focused applications. A rabbit polyclonal Vimentin Antibody provides strong fluorescent signal and enables detailed visualization of Vimentin / VIM filament architecture across neural and cancer cell models.
Titration of the Vimentin Antibody / Neural Cytoskeleton Immunofluorescence Marker Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
This Vimentin Antibody / Neural Cytoskeleton Immunofluorescence Marker Antibody was produced from rabbits immunized with human Vimentin recombinant protein.
Aliquot the Vimentin antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
VIM antibody, Vimentin immunofluorescence antibody, Neural cytoskeleton marker antibody, Glial marker antibody, Cytoskeletal imaging antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.